Navigation Links
Blood Pressure Drugs May Help Heart Patients Without Hypertension
Date:3/1/2011

By Serena Gordon
HealthDay Reporter

TUESDAY, March 1 (HealthDay News) -- In people with heart disease, the use of blood pressure-lowering medications can be beneficial, even in those who don't have high blood pressure, new research suggests.

The study found that when people without high blood pressure were given blood pressure drugs, their risk of congestive heart failure, stroke, all-cause mortality and a combination of cardiovascular disease outcomes were reduced.

"If someone has had a previous heart attack or other cardiovascular event, and their blood pressure is in the normal range, they're still at risk of future cardiovascular events. There may be an additional benefit to giving an anti-hypertensive medication to these folks," said study author Angela M. Thompson, a doctoral research fellow in the department of epidemiology at Tulane University School of Public Health and Tropical Medicine in New Orleans.

"Current treatment recommendations advise treatment when the blood pressure is over 140/90 mm/Hg, but our study shows that you can obtain benefits even when the blood pressure is below that," Thompson explained.

In fact, the risk for cardiovascular disease begins at 115 mm/Hg of systolic pressure (the top number on a blood pressure reading), according to background information in the study.

In addition, in adults 55 years and older, the lifetime risk of developing hypertension is more than 90 percent, the study noted.

The study, which was funded by Tulane University and the National Institutes of Health, was published in the March 2 issue of the Journal of the American Medical Association.

Cardiovascular disease is the leading cause of death in the United States, according to background information in the study. About 54 percent of strokes and 46 percent of heart disease cases occur in people who have blood pressure levels in the normal range, the study reported.

The current study is a meta-analysis of 25 reports that were selected from a pool of 874 studies. The selected studies included almost 65,000 people without high blood pressure, and three-quarters of the study participants were men. All had a history of heart attack or other cardiovascular disease.

Most of the study volunteers were taking blood pressure medications known as beta blockers or angiotensin-converting enzyme (ACE) inhibitors, two commonly used classes of drugs for lowering blood pressure.

The researchers found that people taking blood pressure medications had a 23 percent reduced risk of stroke, a 29 percent reduced risk of congestive heart failure and a 15 percent reduction in the risk of a combination of cardiovascular events. In addition, the risk of cardiovascular mortality was reduced by 17 percent, and the risk of all-cause mortality dropped by 13 percent in those taking these medications compared to those who weren't on the drugs.

Thompson said the researchers don't know exactly how blood pressure medications lowered the risk of cardiovascular events, because this wasn't a study designed to look at the mechanism behind the effect.

He and the other researchers reported no conflicts of interest.

Dr. Mario Garcia, chief of cardiology at Montefiore Medical Center in New York City, said the findings were "not surprising or unexpected. These drugs all have beneficial effects beyond lowering blood pressure. These drugs have already been shown to prevent events in patients with heart attacks or heart failure."

Dr. Hector Ventura, director of cardiomyopathy and heart transplantation at the Ochsner Health System in New Orleans, said, "This study is kind of novel because they looked at people treated with blood pressure medications without hypertension. And, even in people without so-called hypertension, there might be a benefit from these medications," he said.

But, he said, there are still a lot of unanswered questions. In some cases, these medications could make blood pressure too low. And, people would likely need to be on these medications indefinitely, possibly for years. So, costs and potential side effects have to be considered, said Ventura, who wrote an accompanying editorial in the same issue of the journal.

In the editorial, Ventura concluded that the meta-analysis "demonstrates that treatment of blood pressures lower than 140/90 mm/Hg is associated with benefits for patients with [cardiovascular disease], but more clinical trial data are needed for those without CVD."

More information

Learn more about blood pressure medications from the American Heart Association.

SOURCES: Angela M. Thompson, M.S.P.H., doctoral research fellow, department of epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans; Hector Ventura, M.D., director, section of cardiomyopathy and heart transplantation, Ochsner Health System, New Orleans; Mario Garcia, M.D., chief, division of cardiology, Montefiore Medical Center and Albert Einstein College of Medicine, New York City; March 2, 2011, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dramatic Drop in Blood Infections Among ICU Patients: CDC
2. A small subset of normal white blood cells gives rise to a rare leukemia, study shows
3. Simple blood test at discharge could help reduce hospital readmissions for heart failure patients
4. Neighborhood barbers can influence black men to seek blood-pressure treatment
5. Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities
6. Blood pressure management: Sleep on it
7. Advanced degrees add up to lower blood pressure
8. Whole fresh blood for transfusions may have a longer shelf life than now assumed
9. Convenient blood test not as effective for diagnosing diabetes in children
10. Nanoparticles increase survival after blood loss
11. People With Bowel Disease at Higher Risk of Blood Clot in Lungs, Legs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Pressure Drugs May Help Heart Patients Without Hypertension
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
Breaking Medicine Technology: